Serious risks reported with GLP-1 therapy include pancreatitis, gallbladder problems, low blood sugar (particularly alongside other diabetes medicines), kidney issues from dehydration, and allergic reactions
However, studies havent consistently shown improvements in actual exercise performance with ALCAR supplementation. Phaff adds that athletes who take it consistently may notice less soreness and faster recovery, but it works best as a long-term support nutrient, not a same-day performance enhancer
Protocol 1 comprised seven distinct trials (investigating seven separate SUDs), each in a target population of veterans with type 2 diabetes without a history of a specific SUD, assessing the outcome of that specific incident SUD
Of the returned results, studies containing a healthy cohort or control groups consisting of 40 participants or more as part of their study design were included for analysis
This phase of growth will be shaped by rapid expansion in treatment access through private insurance and self-pay channels, increasing clinical adoption for cardiovascular risk reduction, and growing physician confidence in long-term safety profiles
